In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors.

Jean Noel Gouze, Martin J. Stoddart, Elvire Gouze, Glyn D. Palmer, Steven C. Ghivizzani, Alan J. Grodzinsky, Christopher H Evans

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The major requirement of a successful gene transfer is the efficient delivery of an exogenous therapeutic gene to the appropriate cell type with subsequent high or regulated levels of expression. In this context, viral systems are more efficient than nonviral systems, giving higher levels of gene expression for longer periods. For the application of osteoarthritis (OA), gene products triggering anti-inflammatory or chondroprotective effects are of obvious therapeutic utility. Thus, their cognate genes are candidates for use in the gene therapy of OA. In this chapter, we describe the preparation, the use, and the effect of the transduction of chondrocytes or synovial fibroblasts with an adenoviral vector encoding the cDNA for glutamine: fructose-6-phosphate amidotransferase (GFAT). This is intended to serve as an example of a technology that can be used to evaluate the biological effects of overexpression of other cDNAs.

Original languageEnglish (US)
Pages (from-to)147-164
Number of pages18
JournalMethods in molecular medicine
Volume100
StatePublished - 2004
Externally publishedYes

Fingerprint

Chondrocytes
Fibroblasts
Osteoarthritis
Genes
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
Complementary DNA
Therapeutic Uses
Genetic Therapy
Anti-Inflammatory Agents
Technology
Gene Expression
In Vitro Techniques
Therapeutics

Cite this

Gouze, J. N., Stoddart, M. J., Gouze, E., Palmer, G. D., Ghivizzani, S. C., Grodzinsky, A. J., & Evans, C. H. (2004). In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods in molecular medicine, 100, 147-164.

In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. / Gouze, Jean Noel; Stoddart, Martin J.; Gouze, Elvire; Palmer, Glyn D.; Ghivizzani, Steven C.; Grodzinsky, Alan J.; Evans, Christopher H.

In: Methods in molecular medicine, Vol. 100, 2004, p. 147-164.

Research output: Contribution to journalArticle

Gouze, JN, Stoddart, MJ, Gouze, E, Palmer, GD, Ghivizzani, SC, Grodzinsky, AJ & Evans, CH 2004, 'In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors.', Methods in molecular medicine, vol. 100, pp. 147-164.
Gouze JN, Stoddart MJ, Gouze E, Palmer GD, Ghivizzani SC, Grodzinsky AJ et al. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods in molecular medicine. 2004;100:147-164.
Gouze, Jean Noel ; Stoddart, Martin J. ; Gouze, Elvire ; Palmer, Glyn D. ; Ghivizzani, Steven C. ; Grodzinsky, Alan J. ; Evans, Christopher H. / In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. In: Methods in molecular medicine. 2004 ; Vol. 100. pp. 147-164.
@article{9e99ec9356ee4096896decdeabd13af1,
title = "In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors.",
abstract = "The major requirement of a successful gene transfer is the efficient delivery of an exogenous therapeutic gene to the appropriate cell type with subsequent high or regulated levels of expression. In this context, viral systems are more efficient than nonviral systems, giving higher levels of gene expression for longer periods. For the application of osteoarthritis (OA), gene products triggering anti-inflammatory or chondroprotective effects are of obvious therapeutic utility. Thus, their cognate genes are candidates for use in the gene therapy of OA. In this chapter, we describe the preparation, the use, and the effect of the transduction of chondrocytes or synovial fibroblasts with an adenoviral vector encoding the cDNA for glutamine: fructose-6-phosphate amidotransferase (GFAT). This is intended to serve as an example of a technology that can be used to evaluate the biological effects of overexpression of other cDNAs.",
author = "Gouze, {Jean Noel} and Stoddart, {Martin J.} and Elvire Gouze and Palmer, {Glyn D.} and Ghivizzani, {Steven C.} and Grodzinsky, {Alan J.} and Evans, {Christopher H}",
year = "2004",
language = "English (US)",
volume = "100",
pages = "147--164",
journal = "Methods in molecular medicine",
issn = "1543-1894",
publisher = "Humana Press",

}

TY - JOUR

T1 - In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors.

AU - Gouze, Jean Noel

AU - Stoddart, Martin J.

AU - Gouze, Elvire

AU - Palmer, Glyn D.

AU - Ghivizzani, Steven C.

AU - Grodzinsky, Alan J.

AU - Evans, Christopher H

PY - 2004

Y1 - 2004

N2 - The major requirement of a successful gene transfer is the efficient delivery of an exogenous therapeutic gene to the appropriate cell type with subsequent high or regulated levels of expression. In this context, viral systems are more efficient than nonviral systems, giving higher levels of gene expression for longer periods. For the application of osteoarthritis (OA), gene products triggering anti-inflammatory or chondroprotective effects are of obvious therapeutic utility. Thus, their cognate genes are candidates for use in the gene therapy of OA. In this chapter, we describe the preparation, the use, and the effect of the transduction of chondrocytes or synovial fibroblasts with an adenoviral vector encoding the cDNA for glutamine: fructose-6-phosphate amidotransferase (GFAT). This is intended to serve as an example of a technology that can be used to evaluate the biological effects of overexpression of other cDNAs.

AB - The major requirement of a successful gene transfer is the efficient delivery of an exogenous therapeutic gene to the appropriate cell type with subsequent high or regulated levels of expression. In this context, viral systems are more efficient than nonviral systems, giving higher levels of gene expression for longer periods. For the application of osteoarthritis (OA), gene products triggering anti-inflammatory or chondroprotective effects are of obvious therapeutic utility. Thus, their cognate genes are candidates for use in the gene therapy of OA. In this chapter, we describe the preparation, the use, and the effect of the transduction of chondrocytes or synovial fibroblasts with an adenoviral vector encoding the cDNA for glutamine: fructose-6-phosphate amidotransferase (GFAT). This is intended to serve as an example of a technology that can be used to evaluate the biological effects of overexpression of other cDNAs.

UR - http://www.scopus.com/inward/record.url?scp=16644397394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644397394&partnerID=8YFLogxK

M3 - Article

C2 - 15280594

AN - SCOPUS:16644397394

VL - 100

SP - 147

EP - 164

JO - Methods in molecular medicine

JF - Methods in molecular medicine

SN - 1543-1894

ER -